Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/28932| Title: | Caution in expanding the use of abbreviated R-CHOP to poor-risk limited-stage DLBCL. | Authors: | Hawkes E.A.;Hertzberg M.;Opat S. | Institution: | (Hawkes) Department of Clinical Haematology and Medical Oncology, Olivia Newton-John Cancer Research Institute at Austin Health, Heidelberg, VIC, Australia (Opat) Clinical Haematology, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia (Hertzberg) Department of Haematology, Prince of Wales Hospital, University of New South Wales, Randwick, NSW, Australia | Issue Date: | 31-Dec-2020 | Copyright year: | 2020 | Publisher: | American Society of Clinical Oncology | Place of publication: | United States | Publication information: | Journal of Clinical Oncology. 38 (35) (pp 4221-4222), 2020. Date of Publication: 10 Dec 2020. | Journal: | Journal of Clinical Oncology | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1200/JCO.20.02301 | PubMed URL: | 33104442 [http://www.ncbi.nlm.nih.gov/pubmed/?term=33104442] | ISSN: | 0732-183X | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/28932 | Type: | Letter | Type of Clinical Study or Trial: | Opinion, perspective or news |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.